These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 403869)

  • 1. Role of glucagon in diabetes.
    Unger RH; Orci L
    Arch Intern Med; 1977 Apr; 137(4):482-91. PubMed ID: 403869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of glucagon in diabetes.
    Unger RH; Orci L
    Compr Ther; 1982 Jan; 8(1):53-9. PubMed ID: 7039948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glucagon secretion.
    Young A
    Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus secondary to chronic pancreatitis.
    Larsen S
    Dan Med Bull; 1993 Apr; 40(2):153-62. PubMed ID: 8495594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of glucagon in the pathogenesis of diabetes: the status of the controversy.
    Unger RH
    Metabolism; 1978 Nov; 27(11):1691-709. PubMed ID: 360007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoacidosis in pancreatectomized man.
    Barnes AJ; Bloom SR; Goerge K; Alberti GM; Smythe P; Alford FP; Chisholm DJ
    N Engl J Med; 1977 Jun; 296(22):1250-3. PubMed ID: 404553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of experimental insulin deficiency on glucagon secretion.
    Müller WA; Faloona GR; Unger RH
    J Clin Invest; 1971 Sep; 50(9):1992-9. PubMed ID: 4935445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon and diabetes mellitus.
    Reach G; Assan R
    Diabete Metab; 1979 Mar; 5(1):63-70. PubMed ID: 376365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin--clinical implications.
    Ciba Found Symp; 1976; 41():313-50. PubMed ID: 780078
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glucagon in the endogenous hyperglycemia of diabetes mellitus.
    Unger RH; Orci L
    Annu Rev Med; 1977; 28():119-30. PubMed ID: 324351
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin as a physiological modulator of glucagon secretion.
    Bansal P; Wang Q
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E751-61. PubMed ID: 18647881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic alpha-cell dysfunction in diabetes.
    Burcelin R; Knauf C; Cani PD
    Diabetes Metab; 2008 Feb; 34 Suppl 2():S49-55. PubMed ID: 18640586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future alternative therapies in a quest to halt aberrations in diabetes mellitus.
    Adams G; Wang N; Cui Y
    Biomed Pharmacother; 2005 Jul; 59(6):296-301. PubMed ID: 15939570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
    Göke B
    Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric diabetic ketoacidosis and hyperglycemic hyperosmolar state.
    Glaser N
    Pediatr Clin North Am; 2005 Dec; 52(6):1611-35. PubMed ID: 16301085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-islet insulin suppresses glucagon release via GABA-GABAA receptor system.
    Xu E; Kumar M; Zhang Y; Ju W; Obata T; Zhang N; Liu S; Wendt A; Deng S; Ebina Y; Wheeler MB; Braun M; Wang Q
    Cell Metab; 2006 Jan; 3(1):47-58. PubMed ID: 16399504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin].
    Guillemin R; Fontaine M
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2353-6. PubMed ID: 807423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.